EZ-fill® Platform to fasten Scale-up of Fill & Finish Manufacturing capacity for Vaccines

Webinar abstract:

COVID-19 pandemic has highlighted developing countries’ vulnerability due to their reliance on imports for most vaccines and medicines. This is a direct consequence of the lack of local vaccine manufacturing capacity (drug product and fill&finish). The presented Stevanato Group’s ready-to-use drug containment solutions platform helps pharmaceutical companies and their CMO to speed up the installation of fill&finish capacity for vaccines and reduce the Total Cost of Ownership ensuring the highest level of integrity and safety of the drug product.

Key Learning Objectives:

• Local requirements for fill&finish vaccine manufacturing in developing countries
• Ready to use drug containment solutions to meet current and future needs of vaccine manufacturers in developing countries
• Reduce capital expenditure
• Reduce timelines for fill&finish capacity installation and expansion
• Reduce complexity in operations and the need of qualified operators
• Reduction of utility consumption (including WFI)
• Superior integrity and safety of the drug product
• Compliance with EU and US quality and regulatory requirements and guidelines to export in these markets
• Reduce Total Cost of Ownership

The speakers:

• Riccardo Prete - Product Manager Vials Platform, Stevanato Group
• Flavia Batista - Technical Account Management Specialist, Stevanato Group